The M2a Magnum hip implant, which was manufactured by Bimoet Orthopedics before it was acquired by Zimmer to become Zimmer Biomet, was a leading hip replacement product for several years. Unfortunately, thousands of patients who used the M2a line of products reported significant complications, leading to lawsuits against the manufacturer.
Between 1999 and 2009, more than 110,000 of Biomet’s M2a metal-on-metal implant products were implanted in patients throughout the United States. Biomet claimed that the product allowed for a wider range of motion and lower dislocation rates. However, the metal-on-metal design caused metal shavings to be released into the blood and surrounding tissue, leading to a serious medical condition called metallosis. In time, the hip implant could cause tissues to become necrotic (dead), leading to severe pain, swelling and loss of function as well as device failure and potential revision surgery.
Mahoney & Mahoney, LLC is currently reviewing cases involving Biomet hip implants. While the company agreed to settle many lawsuits in 2014, litigation is ongoing with hundreds of lawsuits still pending. If you or a loved one experienced side effects or device failure as the result of a Biomet metal-on-metal hip implant, contact us right away for a free consultation by calling 815-656-4600 or by completing the contact form below.